Finance

Lists
SYRS:OTCMKTS
Syros Pharmaceuticals Inc
US$ ०.०००४०
०.००%
(०.००) 1D
अक्टोबर १४, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SYRS...
Open
US$ ०.००
High
US$ ०.००
Low
US$ ०.००
Mkt. cap
१२.८८ हजार
Avg. vol.
१६.१४ हजार
Volume
३.७५ हजार
52-wk high
US$ ०.०२
52-wk low
US$ ०.००
Beta
१.६६
Shares outstanding
२.६८ करोड
No. of employees
६८
Open
US$ ०.००
High
US$ ०.००
Low
US$ ०.००
Mkt. cap
१२.८८ हजार
Avg. vol.
१६.१४ हजार
Volume
३.७५ हजार
52-wk high
US$ ०.०२
52-wk low
US$ ०.००
Beta
१.६६
Shares outstanding
२.६८ करोड
No. of employees
६८
News stories
From web sources and news partners
About Syros Pharmaceuticals Inc
CEO-
Employees६८
Founded२०११
Headquarters-
Sector-
Websitesyros.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२३ डिसेम्बर
२०२४ मार्च
२०२४ जुन
२०२४ सेप्टेम्बर
Revenue
३.८६ लाख
-
-
-
Cost of goods sold
-
-
-
२.०५ करोड
Cost of revenue
-
-
-
२.०५ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
५६.५५ लाख
Operating expense
-
-
-
५६.५५ लाख
Total operating expenses
-
-
-
२.६२ करोड
Operating income
-
-
-
-२.६२ करोड
Other non operating income
-
-
-
२.०३ करोड
EBT including unusual items
-
-
-
-६३.९६ लाख
EBT excluding unusual items
-
-
-
-६३.९६ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-६३.९६ लाख
Net profit margin
-
-
-
-
Earnings per share
-२.२२
-०.१०
-०.५९
-०.१६
Interest and investment income
-
-
-
७.९३ लाख
Interest expense
-
-
-
-१३.१२ लाख
Net interest expenses
-
-
-
-५.१९ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-२.५९ करोड
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू